Zeolitic imidazolate frameworks : From bactericidal properties to tissue regeneration
Copyright © 2023 Elsevier B.V. All rights reserved..
Zeolitic imidazolate frameworks (ZIFs), as a very well-known subset of metal-organic frameworks (MOFs), have attracted considerable attention in biomedicine due to their unique structural features such as tunable pore size, high surface area, high thermal stability, biodegradability, and biocompatibility. Moreover, it is possible to load a wide variety of therapeutic agents, drugs, and biomolecules into ZIF structures during the fabrication process owing to the ZIFs' porous structure and concise synthesis methods under mild conditions. This review focuses on the most recent advances in the bioinspiration of ZIFs and ZIF-integrated nanocomposites in boosting antibacterial efficiencies and regenerative medicine capabilities. The first part summarizes the various synthesis routes and physicochemical properties of ZIFs, including size, morphology, surface, and pore size. The recent advancements in the antibacterial aspects of using ZIFs and ZIF-integrated nanocomposites as carriers for antibacterial agents and drug cargo are elaborated. Moreover, the antibacterial mechanisms based on the factors affecting the antibacterial properties of ZIFs such as oxidative stress, internal and external triggers, the effect of metal ions, and their associated combined therapies, are discussed. The recent trends of ZIFs and their composites in tissue regeneration, especially bone regeneration and wound healing, are also reviewed with in-depth perspectives. Finally, the biological safety aspects of ZIFs, the latest reports about their toxicity, and the future prospects of these materials in regenerative medicine have been discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:359 |
|---|---|
| Enthalten in: |
Journal of controlled release : official journal of the Controlled Release Society - 359(2023) vom: 01. Juli, Seite 326-346 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kermanian, Mehraneh [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.07.2023 Date Revised 18.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jconrel.2023.06.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357925262 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357925262 | ||
| 003 | DE-627 | ||
| 005 | 20231226073640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jconrel.2023.06.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM357925262 | ||
| 035 | |a (NLM)37290724 | ||
| 035 | |a (PII)S0168-3659(23)00372-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kermanian, Mehraneh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Zeolitic imidazolate frameworks |b From bactericidal properties to tissue regeneration |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.07.2023 | ||
| 500 | |a Date Revised 18.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
| 520 | |a Zeolitic imidazolate frameworks (ZIFs), as a very well-known subset of metal-organic frameworks (MOFs), have attracted considerable attention in biomedicine due to their unique structural features such as tunable pore size, high surface area, high thermal stability, biodegradability, and biocompatibility. Moreover, it is possible to load a wide variety of therapeutic agents, drugs, and biomolecules into ZIF structures during the fabrication process owing to the ZIFs' porous structure and concise synthesis methods under mild conditions. This review focuses on the most recent advances in the bioinspiration of ZIFs and ZIF-integrated nanocomposites in boosting antibacterial efficiencies and regenerative medicine capabilities. The first part summarizes the various synthesis routes and physicochemical properties of ZIFs, including size, morphology, surface, and pore size. The recent advancements in the antibacterial aspects of using ZIFs and ZIF-integrated nanocomposites as carriers for antibacterial agents and drug cargo are elaborated. Moreover, the antibacterial mechanisms based on the factors affecting the antibacterial properties of ZIFs such as oxidative stress, internal and external triggers, the effect of metal ions, and their associated combined therapies, are discussed. The recent trends of ZIFs and their composites in tissue regeneration, especially bone regeneration and wound healing, are also reviewed with in-depth perspectives. Finally, the biological safety aspects of ZIFs, the latest reports about their toxicity, and the future prospects of these materials in regenerative medicine have been discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Antibacterial properties | |
| 650 | 4 | |a Carriers | |
| 650 | 4 | |a Metal-organic frameworks | |
| 650 | 4 | |a Regenerative medicine | |
| 650 | 4 | |a Toxicity | |
| 650 | 7 | |a Imidazoles |2 NLM | |
| 650 | 7 | |a Zeolites |2 NLM | |
| 650 | 7 | |a 1318-02-1 |2 NLM | |
| 650 | 7 | |a Metal-Organic Frameworks |2 NLM | |
| 700 | 1 | |a Nadri, Samad |e verfasserin |4 aut | |
| 700 | 1 | |a Mohammadi, Parvin |e verfasserin |4 aut | |
| 700 | 1 | |a Iravani, Siavash |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmadi, Nahid |e verfasserin |4 aut | |
| 700 | 1 | |a Alinezhad, Vajihe |e verfasserin |4 aut | |
| 700 | 1 | |a Shokrgozar, Mohammad-Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Haddad, Mahdi |e verfasserin |4 aut | |
| 700 | 1 | |a Mostafavi, Ebrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Maleki, Aziz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of controlled release : official journal of the Controlled Release Society |d 1996 |g 359(2023) vom: 01. Juli, Seite 326-346 |w (DE-627)NLM085820296 |x 1873-4995 |7 nnns |
| 773 | 1 | 8 | |g volume:359 |g year:2023 |g day:01 |g month:07 |g pages:326-346 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jconrel.2023.06.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 359 |j 2023 |b 01 |c 07 |h 326-346 | ||